Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
May 21, 2019
Patent Application Number
15407659
Date Filed
January 17, 2017
Patent Citations Received
Patent Primary Examiner
Patent abstract
Methods of selectively inhibiting Akt3 are provided. It has been discovered that 4-[(6-nitroquinolin-4-yl)amino]-N-[4-(pyridin-4-ylamino)phenyl]benzamide selectively inhibits Akt3. Because Akt3 modulates the suppressive function of natural Tregs and the polarization of induced Tregs, 4-[(6-nitroquinolin-4-yl)amino]-N-[4-(pyridin-4-ylamino)phenyl]benzamide can be used for modulating immune responses.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
